Cel-Sci Corp (AMEX:CVM) (was HIV) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV)

CVM 5.160

+3.4%

Jan 16 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Shutters who wrote (2742)	11/15/1999 7:53:00 PM
From: Toni Wheeler	Read Replies (1) of 2836

CEL-SCI Corporation Collaborates With Johns Hopkins University Researchers for Heart Disease <<<VIENNA, Va., Nov. 15 /PRNewswire/ -- CEL-SCI CORPORATION (Amex: HIV; Berlin Stock Exchange:LSR) announces a collaborative study for the treatment, and possible prevention, of autoimmune myocarditis with Noel Rose, M.D., Ph.D., Professor of Pathology and Medicine, at the Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland. Dr. Rose, an expert on autoimmune disease, is considered by many to be the "father" of the field of animal modeling of autoimmune diseases.>>>... www3.techstocks.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next